Ruggero Spoto, MD, Humanitas Research Hospital, Milan, Italy, highlights potential advances in breast cancer radiotherapy. Personalization of radiotherapy treatment for patients would reduce unnecessary treatment impact on patients. To drive personalized treatment, the correct indicators and clinical variables must be identified. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.